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Prediction of Cancer-Associated piRNA–mRNA and
piRNA–lncRNA Interactions by Integrated Analysis of
Expression and Sequence Data
Yajun Liu, Junying Zhang∗ , Aimin Li, Zhaowen Liu, Zhongzhen He, Xiguo Yuan, and Shouheng Tuo
Abstract: piwi-interacting RNAs (piRNAs) are valuable biomarkers, but functional studies are still very limited.
Recent research shows that piRNA-mediated cleavage acts on Transposable Elements (TEs), messenger RNAs
(mRNAs), and long non-coding RNAs (lncRNAs). This study aimed to predict cancer-associated piRNA-mRNA
and piRNA-lncRNA interactions as well as piRNA regulatory functions. Four cancer types (BRCA, HNSC, KIRC,
and LUAD) were investigated. Interactions were identified by integrated analysis of the expression and sequence
data. For the expression analysis, only piRNA–mRNA and piRNA–lncRNA pairs with expression profiles that were
significantly inversely correlated were retained to reduce false-positive rates during the prediction. For the sequence
analysis, miRanda was used for the target prediction. We identified 198 piRNA–mRNA and 10 piRNA–lncRNA
pairs. Unlike mRNA and lncRNA expressions, the piRNA expression was relatively consistent across the cancer
types. Furthermore, the identified piRNAs were consistent with previously published cancer biomarkers, such as
piRNA-36741, piR-21032, and piRNA-57125. More importantly, predicted piRNA functions were determined by
constructing an interaction network, and piRNA targets were placed in gene ontology categories related to the
cancer hallmarks “activating invasion and metastasis” and “sustained angiogenesis”.
Key words: co-expression; piRNA-mRNA interaction; piRNA-lncRNA interaction; integrated analysis; target prediction

1 Introduction
Non-coding RNAs (ncRNAs) can be grouped into two
major classes based on size. Piwi-interacting RNAs
(piRNAs) comprise the largest class of small ncRNAs and
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are expressed in animal cells[1] . They are primarily
expressed in the germline, specifically with Piwi-class
proteins[2] . Similar to micro-RNAs (miRNAs), the 5’ ends
of piRNAs also contain a strong uracil bias[2] . Based on
their origins, piRNAs can be divided into three groups:
transposon-derived piRNAs[3] , mRNA-derived piRNAs,
and lncRNA-derived piRNAs[4] .
1.1

piRNAs in human cancers

Although piRNAs are generally thought to be expressed
in the germline[5] , recent research indicates that piRNAs
can be found in somatic[6] and cancer cells[7] . Cancer
and germ cells share several characteristics, such as
rapid proliferation. Therefore, it is not surprising that
germline factors would also be involved in oncogenesis[8] .
With developments in cancer research, more studies have
highlighted the role of piRNAs in cancer, but functional
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studies remain limited.
Cheng et al.[9] showed that the expression of piR651 in gastric, colon, lung, and breast cancer tissues was
higher than that in paired noncancerous tissues. Their
findings suggest that piR-651 might be involved in the
development of gastric and other cancers and may be a
potential marker for cancer diagnosis. Cheng et al.[9] also
found that the expression level of piR-823 in gastric cancer
tissues was significantly lower than that in noncancerous
tissues. They observed that after increasing the level of
piR-823 in gastric cancer cells, cell growth was inhibited,
suggesting that piR-823 is a putative biomarker for gastric
cancer diagnosis.
Similarly, Cui et al.[10] observed that the levels of
piR-651 and piR-823 in peripheral blood from patients
with gastric cancer were significantly lower than those in
healthy controls. Moreover, they demonstrated that piR823 levels were positively associated with the tumor-nodemetastasis stage and distant metastasis.
Related studies have also revealed similar correlations
in recent years, but are limited to a single piRNA or a few
expression profiles. Martinez et al.[7] analyzed 6260 human
piRNA transcriptomes derived from non-malignant and
tumor tissues from 11 organs. They discovered that a total
of 522 piRNAs were expressed in all tumor tissues. This
public piRNA expression data could be used to support
future piRNA functional studies.
1.2 piRNA co-expression analysis
One of the main tasks in piRNA research is functional
analysis. Genes typically have dependencies on each
other. Martinez et al.[7] analyzed correlations in piRNA
expression patterns across samples within the same tumor
type and found distinct clusters in similarity matrices.
Intriguingly, piRNA expression was associated with
clinically relevant features of individual tumor types. We
believe that piRNAs form an information network inside
the cell and that appropriate statistical methods can be used
for elucidating these networks.
1.3 piRNA–mRNA and piRNA–lncRNA interactions
The most well-known piRNA function is piRNA-mediated
cleavage of Transposable Elements (TEs). However,
recent research has shown that piRNAs are also involved
in the regulation of mRNAs and lncRNAs.
Watanabe et al.[12] showed that piRNAs derived from
transposons and pseudogenes mediate the degradation
of many mRNAs and lncRNAs in murine late
spermatocytes. Their genomic and in vivo functional
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analyses revealed that retrotransposon sequences in
the 3’ UTRs of mRNAs are targeted by piRNAs for
degradation. Similarly, the degradation of spermatogenic
cell-specific lncRNAs by piRNAs is mediated by
retrotransposon sequences.
Gou et al.[13] reported the involvement of pachytene
piRNAs in directing massive elimination of mRNAs in
murine Elongating Spermatids (ES). They demonstrated
that a piRNA-Induced Silencing Complex (pi-RISC)
containing Murine PIWI (MIWI) and the deadenylase
CAF1 is selectively assembled in ES and is responsible for
inducing mRNA deadenylation and decay via a mechanism
that resembles the action of miRNAs in somatic cells.
Prediction algorithms for piRNA targets in mice have
begun to emerge. Yuan et al.[14] trained a support
vector machine classifier using a combination of MIWI
CLIP-Seq-derived features and position-derived features
to predict potential mRNA targets of piRNAs. However,
this software is specifically trained for mice rather than
humans.
Considering the well-known roles of miRNAs in
mRNA and lncRNA deadenylation in oncogenesis, we
utilized this piRNA mechanism as a focus of cancer
research and hypothesized that the expression of a piRNA
may be inversely correlated to that of its target. As piRNA
regulation results in some disease conditions, an increase
in the expression levels of the target should correspond
to a decrease in the expression levels of its piRNA, and
vice versa. Our study aimed to predict cancer-associated
piRNA–mRNA and piRNA-lncRNA interactions and to
predict piRNA functions using these interactions.

2

Materials and Methods

2.1
2.1.1

Datasets
Expression data

piRNA expression data was obtained from Martinez
et al.[7] The expression data contained a total of
522 expressed piRNAs in corresponding tumor tissues.
Meanwhile, gene expression profiles containing coded
RNAs and lncRNAs were obtained from the Synapse
archive (www.synapse.org), including the following
accessions: syn1461149 (BLCA), syn1461151 (BRCA),
syn1461155 (COAD), syn1461156 (HNSC), syn1461159
(KIRC), syn1461166 (LUAD), syn1461168 (LUSC),
syn1461171 (OV), syn1461173 (PRAD), syn1461177
(STAD), syn1461178 (THCA), and syn1461180 (UCEC).
Categorical annotations of the genes were acquired using
NCBI FTP[15] , and 18 633 protein-coding RNAs and 795
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lncRNAs were considered in the next research step.
For subsequent correlation coefficient analysis, four
tumor types (BRCA, HNSC, KIRC, and LUAD) with
more than 20 samples each were selected. The number
of samples for each corresponding tumor type is listed in
Table 1.
2.1.2 Sequence data
We obtained 75 669 human 3’ UTRs from among
18 171 mRNA and 167 lncRNA sequences from the
Ensembl database build 19 34b[16] using the R package
“biomaRt”[17] .
Human piRNA sequence data were
collected by the University of California, Santa Cruz
(UCSC) and accessed using the Genome Bioinformatics
site (http://genome.ucsc.edu/)[18] .
2.1.3 Gene-derived piRNA data
In the piRBase database[19] , piRNAs mapped to RefSeq
genes[20] or repeat elements annotated by RepeatMasker[21]
were identified. Among these, mRNA-derived piRNAs
were downloaded.
2.2 Overview of methodology
The structure of our method is presented in Fig. 1 and
is divided into two main parts: expression data analysis
Table 1
Expression

Samples and tissue types studied.

TCGA code

profile type (for tumor types)

Number of

Number of

normal samples

tumor samples

Genes

BRCA

104

822

(coding

HNSC

37

303

RNAs and

KIRC

68

470

lncRNAs)

LUAD

57

355

BRCA

103

1043

HNSC

43

455

KIRC

71

529

LUAD

46

497

piRNAs

and sequence data analysis. Expression data analysis was
used for reducing false-positive rates during predictions,
and sequence data analysis was employed for predicting
piRNA targets and target down-regulation scores.
During expression data analysis, piRNA–target pair
identification was performed based on a multi-stage
filtering approach. First, only differentially expressed
mRNAs and lncRNAs remained after stage 1, and piRNAs
expressed in the corresponding cancers were selected
in stage 2. Next, correlations between the piRNAs
and candidate targets were analyzed in stage 3. Only
piRNA–candidate pairs whose expression profiles were
significantly inversely correlated were retained. Further
details are explained in the following section.
For sequence data analysis, only the expressed
piRNAs and differentially expressed candidates in
the four cancer types were considered as input.
miRanda[22, 23] (www.microrna.org), a well-known miRNA
target software, was used for the target prediction. The
intersection of miRanda results and correlation analysis
results was retained. A potential set of piRNA–target pairs
was obtained after filtering out mRNA-derived piRNAs
and precursor mRNAs as well as piRNA–candidate pairs
that only exist in one cancer type.
2.2.1

Schematic of prediction pipeline.

Filtering stage 1 (mRNA and lncRNA filtering)

To identify cancer-related piRNA–target interactions,
differentially expressed mRNAs and lncRNAs in casecontrol paired samples were considered as candidates,
a majority of which were shown to be correlated with
carcinogenesis and metastasis in most types of cancer.
Therefore, the DESeq library[24] was applied to analyze the
mRNA and lncRNA expression data in this study. There
were three standards when considering whether a gene
was significantly differentially expressed: an FDR value
< 0.05, a p-value < 0.05, and a fold-change > 2. No
differentially expressed mRNAs or lncRNAs were filtered
out in the first stage of prediction.
2.2.2

Fig. 1
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Filtering stage 2 (piRNA filtering)

As a class of small ncRNAs, piRNA expression patterns in
tumors are unique. Martinez et al.[7] noticed that only 522
piRNAs were expressed in corresponding tumor tissues.
Globally, piRNA expression levels were considerably
lower in non-malignant tissues compared with levels in
tumor tissues, except for BRCA and KIRC tumors, which
showed levels comparable to those observed in nonmalignant tissues. In addition, of the 522 expressed
piRNAs, 324 were significantly differentially expressed
between non-malignant and tumor tissues, most of which
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were overexpressed in tumors compared to levels in nonmalignant tissues, with 135 piRNAs exclusively expressed
in tumors[7] .
In this study, all 522 expressed piRNAs in the
corresponding tumor tissues were retained in the second
stage of prediction. This was because piRNAs that target
differentially expressed genes may not themselves be
differentially expressed.
2.2.3 Filtering
filtering)

stage

3

(piRNA–candidate

pair

Correlation analysis between piRNAs–mRNAs and
piRNAs–lncRNAs was performed by sample-paired
expression profiles. It is worth noting that expression
levels were calculated in normal and tumor samples
for each cancer. Spearmans rank correlation was used,
which is ideal for detecting nonlinear relationships. The
Spearmans rank correlation and the corresponding p-value
were calculated using the function cor() in R language.
piRNAs are known to degrade mRNAs and regulate
lncRNAs. Based on the evidence, we hypothesized that
the expression of a target may be inversely correlated to
that of its corresponding piRNA. Hence, piRNA-candidate
pairs were retained only when their expression profiles
were significantly inversely correlated both in normal and
tumor samples.
In addition, piRNA co-expression analysis was used
for inferring piRNA associations. Spearmans correlationbased matrices were calculated for each tumor type
and piRNA co-expression networks were constructed for
piRNA function research.

cancer type were removed. In addition, mRNA-derived
and lncRNA-derived piRNAs as well as their precursors
were first filtered out. As mentioned in Section 1, some
mRNAs, transposons, and lncRNAs are likely precursor
molecules that are processed into small RNAs such as
piRNAs. Among these, mRNA-derived piRNAs are on
the same sense strand as the mRNA from which they
are processed and often originate from 3’ UTRs. Those
piRNAs and their precursors were identified and filtered
out based on the piRBase database[19] . lncRNA-derived
piRNAs and their precursors were tested by UCSC[18] .
DAVID 6.7 (https://david.ncifcrf.gov/home.jsp)[25, 26]
was used for gene ID conversion. A classic alignment
algorithm, the Needleman-Wunsch algorithm, was used
for piRNA sequence alignment.

3
3.1

Results and Discussion
Results of differential expression analysis

Gene expression data for four cancer types were used
for differential expression analysis of case-control paired
samples. Gene probes of expression data contained 795
ncRNAs and 18 633 protein-coding RNAs.
The results are displayed in Venn diagrams (Figs. 2a
and 2b), which show that a significant number of mRNAs
and lncRNAs were exclusively expressed in individual
tumor types. In contrast, the variation in the expression
of piRNAs among cancers was small (Fig. 2c). As a
class of small ncRNAs, the number of expressed piRNAs
was far less than the number of differentially expressed

2.2.4 Prediction of piRNA–target pairs (miRanda)
Because of the similarities in patterns of
degradation/regulation between piRNAs and miRNAs, a
well-known miRNA–target prediction software program
was used for piRNA–target prediction. Gou et al.[13]
searched for potential targeting sites of MIWI-associated
piRNAs within the 3’ UTRs of MIWI-associated mRNAs
using the miRanda software[23] . Based on their approach,
we also used miRanda for target prediction. The 3’ UTR
sequences of differentially expressed mRNAs, sequences
of differentially expressed lncRNAs, and sequences of
expressed piRNAs were collected as input for miRanda.
2.2.5 Intersection & filtering stage 4 (piRNA–
candidate pair filtering)
To improve the prediction credibility, the intersection of
the miRanda and correlation analysis results was selected
as input for filtering stage 4. In the last filtering stage,
piRNA–candidate pairs that only existed in a specific

Fig. 2

Venn diagrams for four cancers. (a) Differentially

expressed mRNAs, (b) differentially expressed lncRNAs, (c)
expressed piRNAs, and (d) differentially expressed piRNAs.
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mRNAs for each cancer type.
Furthermore, referring to Martinez et al.[7] , differential
expression analyses of piRNAs were performed using the
Comparative Marker Selection module implemented in
the gene pattern[27, 28] . The results showed that there is
still a large overlap in the piRNAs that are differentially
expressed in the four cancers (Fig. 2d). We believe that
research on the piRNAs involved in pan-cancer represents
a new area of focus in the field of functional analysis.
3.2 piRNA co-expression analysis
Co-expression analysis is a common tool for inferring
gene associations and functions using expression data and
can be applied to piRNAs. Spearman’s correlation-based
matrices were calculated as well as piRNA co-expression
networks for the four cancer tissues and noncancerous
(control) tissues. Figure 3 demonstrates the use of
CytoScape[29] to visualize interactions between the BRCA
tumor and adjacent noncancerous tissues.
The degree of centrality is defined as the number
of links one node has to another, which determines the
relative importance of a gene. In addition, k-cores
were applied as a method of simplifying graph topology
analyses. Core regulatory factors (piRNAs), which have
the highest degrees, connect the most adjacent piRNAs and
build the structure of the network.
There were more connections among piRNAs in cancer
tissues than in control tissues, suggesting that most of
the physiological piRNA–piRNA interactions and linkages
in normal tissues had been altered in the cancer tissues.
The piRNAs with high degrees of centrality and k-cores,

Fig. 3
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indicating that they possessed most of the interactions
with other piRNAs, were considered key piRNAs in
the interaction network and are listed in Table 2. The
biological relevance of these key piRNAs requires further
Table 2

Top 5 piRNAs with highest degrees of centrality

and k-cores in co-expression networks of four cancers and
adjacent noncancerous tissues.
Co-expression networks
in tumor samples
Tumor PiRNA
type
name

k-

Co-expression networks
in normal samples
PiRNA

k-

core

Degree

name

core

Degree

FR301191

4

23

FR228545

2

12

FR237180

4

14

FR114004

2

3

BRCA FR106521

4

13

FR296333

2

2

FR348209

4

8

FR378984

2

2

FR270731

4

4

FR301191

1

5

FR301191

6

56

FR301191

6

38

FR237180

6

26

FR202919

6

28

HNSC FR214430

6

24

FR037883

6

26

FR090905

6

6

FR270731

6

14

FR236484

6

6

FR190827

6

10

FR237180

4

28

FR237180

2

22

FR072386

4

22

FR136623

2

20

KIRC FR136623

4

16

FR072386

2

6

FR210409

4

10

FR163199

2

6

FR131044

4

6

FR381169

2

6

FR301191

10

52

FR228545

4

46

FR321895

10

36

FR252722

4

22

LUAD FR384068

10

34

FR136216

4

12

FR202919

10

32

FR125672

4

10

FR145670

10

24

FR384068

4

10

Co-expression network of piRNAs in normal and cancerous tissues. (a) Co-expression network in BRCA, and (b)

co-expression network in adjacent noncancerous tissues.
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exploration.
3.3 Correlation analysis
piRNAs exert their function through mRNA and lncRNA
deadenylation. Consequently, we hypothesized that the
expression of a piRNA target would be inversely correlated
to that of the piRNA.
Correlation analysis was performed using piRNA,
mRNA, and lncRNA expression data in individual
tumor types. In BRCA, for example, 3391 differentially
expressed mRNAs, 103 differentially expressed lncRNAs,
and 274 expressed piRNAs were considered. Paired gene
(coding RNAs and lncRNAs) and piRNA expression data
were calculated both in normal and tumor tissues.
From Fig. 4, each histogram of correlation values
conforms to the normal distribution. In addition, the

Fig. 4

wilcoxon rank sum test is used to test the difference
between the case and control correlation, with a p-value
< 2.2−16.
In this study, we focused on significant inverse
correlations between piRNA–candidate pairs (cor
< 0, p < 0.05) in both normal and tumor samples
simultaneously. The results are provided in Table 3.
3.4

Results of miRanda

Based on expression data analysis, 8221 mRNAs, 254
lncRNAs, and 323 piRNAs were obtained. Among these
mRNAs, 18 173 3’ UTR sequences from 7321 mRNAs
were available in the Ensembl database[16] and downloaded
by the R package “biomaRt”[17] .
In addition, 167
differentially expressed lncRNA sequences were obtained

Histograms of correlation values between piRNA-gene pairs in (a) BRCA control samples and (b) BRCA cases; (c)

HNSC control samples and (d) HNSC cases; (e) KIRC control samples and (f) KIRC cases; (g) LUAD control samples; and (h)
LUAD cases.
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Results of significant inverse correlation analysis.

TCGA code
(for tumor
code)

Number of significant inverse correlation
piRNA-gene pairs
Normal samples

Tumor samples

Intersection

BRCA

90 362

156 130

26 519

HNSC

36 846

61 006

5351

KIRC

76 242

87 480

14 921

LUAD

29 061

116 482

4529

the same way. Furthermore, 323 piRNA sequences were
collected by UCSC[18] .
The above sequences were used as input for the
miRanda software[23] to predict piRNA targets from the 3’
UTRs of mRNAs and lncRNAs using the options “-strict quiet”. As a result, 711 073 piRNA–mRNA pairs (458 008
unique pairs) and 100 620 piRNA–lncRNA pairs (38 770
unique pairs) were obtained by miRanda.
3.5 piRNA–mRNA and piRNA–lncRNA interaction
analysis
3.5.1 Analysis of predicted pair sets
After filtering of mRNA-derived piRNAs, 3687 piRNA–
mRNA pairs in BRCA, 800 pairs in HNSC, 1955 pairs
in KIRC, and 693 pairs in LUAD were preserved. By
analyzing these sets of predicted mRNAs, 2143 of 2639
mRNAs (81.2%) were found to be expressed in a specific
cancer (Fig. 5a). After lncRNA-derived piRNAs were
filtered, 479 piRNA–lncRNA pairs in BRCA, 62 pairs
in HNSC, 451 pairs in KIRC, and 31 pairs in LUAD
were preserved. By analyzing these sets of predicted
lncRNAs, 104 out of 132 mRNAs (78.8%) were found to
be expressed in a specific cancer (Fig. 5b).
In contrast, a small percentage of piRNAs (24.6%)
were specifically expressed, and the intersection of
piRNAs among the four sets was 55 (29.4%) (Fig.
5c). These results imply that the predicted piRNAs are
consistent across cancer types, and their functions may

Fig. 5
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therefore be related to pan-cancer.
3.5.2

Agreement
biomarkers

with

known

piRNA

cancer

To date, the exact role of piRNAs in cancer has not
been extensively studied. Relative data and reports
mainly concern mice and rarely involve humans. A
closer look at the predicted piRNAs revealed that
three piRNAs had been reported as potential cancer
biomarkers in previous studies, including piR-36741 (5’GTTTAGACGGGCTCACATCAC-3’), piR-21032 (5’TAAAGTGCTGACAGTGCAGATAGTGGTCCTC-3’),
and piR-57125 (5’-TGGTCGTGGTTG TAGTCCGTG3’)[30, 31] . Yang et al.[31] reported that these piRNAs are
stably expressed in human serum or plasma samples and
can serve as valuable blood-based biomarkers for disease
detection and monitoring.
3.5.3

Interaction network analysis

We focused on piRNA–mRNA and piRNA–lncRNA
interactions exclusively related to tumors and selected 198
piRNA–mRNA and 10 piRNA–lncRNA pairs shared by at
least two cancers from which to construct a network.
Similar to the miRNA regulatory mechanism, we
speculated that the lower the free energy of the piRNA–
target pair, the greater the binding affinity. Hence,
we used the minimum free energy of the piRNA–target
binding and CytoScape[29] to visualize these interactions,
as shown in Fig. 6. In this network, most mRNAs can be
identified as potential targets of one or two piRNAs, and
a piRNA may target one or more mRNAs. While half
of the key piRNAs in the network have only one or two
interactions, we believe that the biological meaning of the
interactions between key piRNAs and their target mRNAs
and lncRNAs is worthy of future attention.
3.5.4

Functional analysis

We investigated the potential functions of piRNAs by

Venn diagrams of (a) predicted mRNAs, (b) predicted lncRNAs, and (c) predicted piRNAs in the four cancers.
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Fig. 6

piRNA–mRNA interaction network showing key piRNAs listed in Table 3 (blue chevrons), remaining piRNAs (blue

ovals), mRNAs (red rectangles), and lncRNAs (red triangles). Intensity of each red node indicates the minimum free energy for
all interactions with that node.

analyzing their mRNA targets using Webgestalt[32, 33] ,
which is a suite of tools for functional enrichment analysis
in various biological contexts. We analyzed all 128
non-cancer-type-specific genes, and the most enriched
biological processes are shown in red as a Directed Acyclic
Graph (DAG) in Fig. 7.
The most significant biological function was blood
vessel development, which is closely related to the cancer
hallmark sustained angiogenesis. Another significant GO
term cell adhesion is highly related to the cancer hallmark
activating invasion and metastasis. These indicate potential
roles for piRNAs in cancer, which should be studied
further.

4 Conclusion
In addition to their transposon regulatory function,
piRNAs may also target and regulate the expression
of mRNAs. It is also possible that piRNAs may be
involved in tumorigenesis through the regulation of cancerrelated genes. Furthermore, gene expression analyses
conducted on cancers have previously been used to predict
diagnostic markers and to identify gene expression patterns
associated with prognosis but have not been used to reveal
interactions between piRNAs and mRNAs/lncRNAs. This
study aimed to predict cancer-associated piRNA–mRNA
and piRNA–lncRNA interactions and to predict piRNA
regulatory functions based on those interactions.
Based on the quality and quantity of expression data,
four cancers (BRCA, HNSC, KIRC, and LUAD) were
selected. Corresponding piRNA–mRNA interactions were

identified by integrated analysis of piRNA and mRNA
expression and sequence data. We predicted 198 piRNA–
mRNA interactions related to cancer.
The results showed that in contrast with gene
expression, piRNA expression is relatively consistent
among the four cancers. Furthermore, the identified
piRNAs are consistent with previously published cancer
biomarkers, as in the case of piRNA-36741, piRNA21032, and piRNA-57125. More importantly, potential
piRNA functions were predicted by constructing an
interaction network and analyzing piRNA targets. These
targets were enriched in gene ontology categories related
to the cancer hallmarks activating invasion and metastasis
and sustained angiogenesis. We believe that piRNAs are
closely related to cancer development and require further
study.
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